Below is the post from my discussion post, help me providing a…

Question Answered step-by-step Below is the post from my discussion post, help me providing a… Below is the post from my discussion post, help me providing a response to the post below by agreeing or pointing out something that caught attention. Please provide references-The opioid epidemic is dynamic, complex, and rapidly changing. Data from the California Department of Public Health indicates that California has reduced unsafe prescribing; however, even with this decrease, prescription opioids are still the leading cause of opioid overdose deaths (2021). Additionally, the number of overdose deaths related to heroin, Fentanyl, and amphetamines is increasing. Any Opioid-related overdose deaths totaled 3,244, and Fentanyl related overdose death totaled 1,603 in 2019 (California Department of Public Health, 2021).The State of California is taking action against the opioid epidemic. The California Assembly, Medical Board, and Department of Justice are working together to reduce the risk of death associated with prescription opioids. On September 5, 2019, Assembly Bill No. 714, Opioid prescription drugs: prescribers, was approved by California Governor. This bill is an act to amend Sections 740 and 741 of the Business and Professions Code, relating to healing arts, and declaring the urgency thereof, to take effect immediately (California Legislative Information, 2019). This bill’s sponsor was an American politician Jim Wood currently serving in the California State Assembly. He is a Democrat representing the 2nd Assembly District, which encompasses parts of California’s North Coast.Existing law requires a prescriber to offer a patient a prescription for naloxone, hydrochloride, or another drug approved by the United States Food and Drug Administration to complete or partial reversal of opioid depression when certain conditions are present. The provider should provide education on overdose prevention to patients receiving a prescription and specified other persons if they present an increased risk for overdose or a history of a substance use disorder. (California Legislative Information, 2019).Dealing with opioid addiction is one of the most significant issues the U.S. health system faces today, and nurses are playing a key role in our nation’s efforts to deal with the crisis. Registered nurses are qualified and well-positioned to play a leading role in assessing, diagnosing, and managing patient opioid addiction. The American Nurses Association (ANA) Code of Ethics states the nurse “uses advocacy, education, and a supportive approach to honor the patient’s right to self-determination, autonomy, and dignity” (2018). All nurses have an ethical obligation to provide respectful, individualized care to all patients experiencing pain regardless of their characteristics, values, or beliefs. American Nurses Association (2018) also stated that Advanced Practice Registered Nurses’ education prepares them to assume responsibility and accountability for assessing, diagnosing, and managing patients’ problems, including the use and prescription of opioids and other pharmacologic interventions. The APRN should take a proactive approach by assessing and reassessing patients for pain frequently. Ultimately, Stakeholders, professional societies, and clinicians will need to continue to work together to clarify clinical practice guidelines to ensure that patients receive appropriate pain management while minimizing their risk for opioid misuse (Meghani & Vapiwala, 2018).ReferencesAmerican Nurses Association (2018). The Opioid Epidemic: The Evolving Role of Nursing. Retrieved from https://www.nursingworld.org/~4a4da5/globalassets/practiceandpolicy/work-environment/health–safety/opioid-epidemic/2018-ana-opioid-issue-brief-vfinal-pdf-2018-08-29.pdf (Links to an external site.)California Legislative Information (2019). AB-714 Opioid prescription drugs: prescribers. https://leginfo.legislature.ca.gov/faces/billNavClient.xhtml?bill_id=201920200AB714 (Links to an external site.)Meghani, S.H., Vapiwala, N. (2018). Bridging the critical divide in pain management guidelines from the CDC, NCCN, and ASCO for cancer survivors. JAMA Oncology, 4 (10) (2018), 1323-1324 Retrieved from https://pubmed.ncbi.nlm.nih.gov/29852051/ Health Science Science Nursing NR 503 Share QuestionEmailCopy link Comments (0)